Share on StockTwits

Repligen Corp. (NASDAQ:RGEN) will issue its Q114 quarterly earnings data on Monday, August 11th. Analysts expect the company to announce earnings of $0.06 per share and revenue of $14.90 million for the quarter.

Repligen Corp. (NASDAQ:RGEN) opened at 21.21 on Friday. Repligen Corp. has a one year low of $9.41 and a one year high of $24.68. The stock has a 50-day moving average of $22.52 and a 200-day moving average of $17.69. The company has a market cap of $679.5 million and a P/E ratio of 38.41.

A number of research firms have recently commented on RGEN. Analysts at Janney Montgomery Scott initiated coverage on shares of Repligen Corp. in a research note on Thursday, June 26th. They set a “buy” rating and a $26.00 price target on the stock. Analysts at Jefferies Group raised their price target on shares of Repligen Corp. from $20.00 to $22.00 in a research note on Wednesday, June 4th. They now have a “buy” rating on the stock.

Repligen Corporation is a United States-based life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs.

Receive News & Ratings for Repligen Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repligen Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.